These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34305008)

  • 21. Shorter turn-around-time and improved patient care in peripheral blood progenitor cell collection procedures.
    Ratcliffe N; Blume C; John P; Weiss T; Hubbell C; Henry JB
    J Clin Apher; 1999; 14(1):35-41. PubMed ID: 10355662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of a quality system (ISO 9000 series) for placental blood banking.
    Sirchia G; Rebulla P; Lecchi L; Mozzi F; Crepaldi R; Parravicini A
    J Hematother; 1998 Feb; 7(1):19-35. PubMed ID: 9507378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP).
    Manchikanti L; Centeno CJ; Atluri S; Albers SL; Shapiro S; Malanga GA; Abd-Elsayed A; Jerome M; Hirsch JA; Kaye AD; Aydin SM; Beall D; Buford D; Borg-Stein J; Buenaventura RM; Cabaret JA; Calodney AK; Candido KD; Cartier C; Latchaw R; Diwan S; Dodson E; Fausel Z; Fredericson M; Gharibo CG; Gupta M; Kaye AM; Knezevic NN; Kosanovic R; Lucas M; Manchikanti MV; Mason RA; Mautner K; Murala S; Navani A; Pampati V; Pastoriza S; Pasupuleti R; Philip C; Sanapati MR; Sand T; Shah RV; Soin A; Stemper I; Wargo BW; Hernigou P
    Pain Physician; 2020 Mar; 23(2):E85-E131. PubMed ID: 32214287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.
    Reed W; Noga SJ; Gee AP; Rooney CM; Wagner JE; McCullough J; McKenna DH; Whiteside TL; Donnenberg AD; Baker AK; Lindblad RW; Wagner EL; Mondoro TH
    Transfusion; 2009 Apr; 49(4):786-96. PubMed ID: 19170985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obtaining an accepted Investigational New Drug application to operate an umbilical cord blood bank.
    Reems JA; Fujita D; Tyler T; Moldwin R; Smith SD
    Transfusion; 1999 Apr; 39(4):357-63. PubMed ID: 10220260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
    Yim R
    Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity.
    Thibodeaux SR; McKenna DH; Szczepiorkowski ZM; Fontaine MJ; Kelley L; Reems JA; Young PP;
    Transfusion; 2020 Aug; 60(8):1811-1820. PubMed ID: 32654200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
    Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.
    Nguyen L; Leach A; Piwowar-Manning E; Marzinke M; Levesque A; Gregorio C; Skinner K; Towindo T; Hanes H; Sarpong K; Kasongo C; Samsunder N; Aldrovandi G; Ferbas KG; Engelbrecht A; Stirewalt M; Anyango E; Ubolyam S; Lankford-Turner P; Sarzotti-Kelsoe M
    AIDS Res Hum Retroviruses; 2024 Nov; 40(11):622-630. PubMed ID: 39135473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the blood bank in transplantation.
    McCullough J
    Arch Pathol Lab Med; 1991 Dec; 115(12):1195-200. PubMed ID: 1768207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a configurable laboratory information management system for use in cellular process development and manufacturing.
    Russom D; Ahmed A; Gonzalez N; Alvarnas J; DiGiusto D
    Cytotherapy; 2012 Jan; 14(1):114-21. PubMed ID: 21973024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concluding commentary on current trends to enhance the clinical safety of pediatric transfusion, focusing on prevention of untoward complications of HSC transplantation & newer strategies for improving the standards of safety/quality of stem cells expansion for cellular therapy.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):378-383. PubMed ID: 29778713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.
    Talarmin C; Kerob S; Cartier F; Madelaine I; Mukenyi S; Schwartz E; Boissel N; Baruchel A; Thieblemont C; Parquet N; Brignier A; Lesprit E; Desproges A; Magdelonnette L; Larghero J; Mebarki M
    Cytotherapy; 2020 Dec; 22(12):792-801. PubMed ID: 32732084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.
    Sampalis JS; Watson J; Boukas S; Boukas M; Harvey N; Machado S; Bordeleau M; Rampakakis E
    Surgery; 2017 Mar; 161(3):576-583. PubMed ID: 28190508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
    Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
    Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?
    Chen LN; Collins-Johnson N; Sapp N; Pickett A; West K; Stroncek DF; Panch SR
    Transfusion; 2019 Aug; 59(8):2506-2518. PubMed ID: 31135995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.